{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:02:32Z","timestamp":1793833352890,"version":"4.6.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was supported by a grant from Linyi Science and Technology Development Program, China.","award":["(201919010)"],"award-info":[{"award-number":["(201919010)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Inflamm"],"DOI":"10.1186\/s12950-025-00449-7","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:25:15Z","timestamp":1750667115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The soluble epoxide hydrolase inhibitor TPPU alleviates A\u03b2-mediated neuroinflammatory responses in Drosophila melanogaster and cellular models of alzheimer\u2019s disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaowen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna C.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"449_CR1","first-page":"a006189","volume":"11","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in alzheimer disease. Cold Spring Harbor Perspect Med. 2011;11:a006189.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"449_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"39710284","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet (London England). 2021;39710284:1577\u201390.","journal-title":"Lancet (London England)"},{"key":"449_CR3","first-page":"e105","volume":"72","author":"Estimation of the global prevalence of dementia","year":"2022","unstructured":"Estimation of the global prevalence of dementia. In 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health. 2022;72:e105\u201325.","journal-title":"Lancet Public Health"},{"key":"449_CR4","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","volume":"1013","author":"C Ferrari","year":"2021","unstructured":"Ferrari C, Sorbi S. The complexity of alzheimer\u2019s disease: an evolving puzzle. Physiol Rev. 2021;1013:1047\u201381.","journal-title":"Physiol Rev"},{"key":"449_CR5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.drudis.2022.01.016","volume":"274","author":"SA Tatulian","year":"2022","unstructured":"Tatulian SA. Challenges and hopes for alzheimer\u2019s disease. Drug Discovery Today. 2022;274:1027\u201343.","journal-title":"Drug Discovery Today"},{"key":"449_CR6","doi-asserted-by":"publisher","first-page":"e12295","DOI":"10.1002\/trc2.12295","volume":"81","author":"J Cummings","year":"2022","unstructured":"Cummings J, Lee G, Nahed P, Kambar M, Zhong K, Fonseca J, et al. Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimers Dement (New York, N Y). 2022;81:e12295.","journal-title":"Alzheimers Dement (New York, N Y)."},{"key":"449_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-018-0107-y","volume":"7","author":"X Du","year":"2018","unstructured":"Du X, Wang X, Geng M. Alzheimer\u2019s disease hypothesis and related therapies. Translational Neurodegeneration. 2018;7:2.","journal-title":"Translational Neurodegeneration"},{"key":"449_CR8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"126","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P. Neuroinflammation in alzheimer\u2019s disease: current evidence and future directions. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2016;126:719\u201332.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"449_CR9","doi-asserted-by":"crossref","unstructured":"Cheng J, Dong Y, Ma J, Pan R, Liao Y, Kong X et al. Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer\u2019s disease pathology. Sci Adv. 2021;7:eabe3600.","DOI":"10.1126\/sciadv.abe3600"},{"key":"449_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"173","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in alzheimer disease: where do we go from here? Nat Reviews Neurol. 2021;173:157\u201372.","journal-title":"Nat Reviews Neurol"},{"key":"449_CR11","doi-asserted-by":"publisher","first-page":"856376","DOI":"10.3389\/fimmu.2022.856376","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y, Liu J, Wang B, Sun M, Yang H. Microglia in the neuroinflammatory pathogenesis of alzheimer\u2019s disease and related therapeutic targets. Front Immunol. 2022;13:856376.","journal-title":"Front Immunol"},{"key":"449_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"2172","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in alzheimer\u2019s disease. J Cell Biol. 2018;2172:459\u201372.","journal-title":"J Cell Biol"},{"key":"449_CR13","doi-asserted-by":"crossref","unstructured":"Al-Ghraiybah NF, Wang J, Alkhalifa AE, Roberts AB, Raj R, Yang E, et al. Glial Cell-Mediated Neuroinflammation in Alzheimer\u2019s Disease. Int J Mol Sci. 2022;23:10572.","DOI":"10.3390\/ijms231810572"},{"key":"449_CR14","doi-asserted-by":"crossref","unstructured":"Piccioni G, Mango D, Saidi A, Corbo M, Nistic\u00f2 R. Targeting Microglia-Synapse Interactions in Alzheimer\u2019s Disease. Int J Mol Sci. 2021;22:2342.","DOI":"10.3390\/ijms22052342"},{"key":"449_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3109\/00207454.2013.833510","volume":"1245","author":"Z Cai","year":"2014","unstructured":"Cai Z, Hussain MD, Yan LJ. Microglia, neuroinflammation, and beta-amyloid protein in alzheimer\u2019s disease. Int J Neurosci. 2014;1245:307\u201321.","journal-title":"Int J Neurosci"},{"key":"449_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12931-021-01891-w","volume":"221","author":"Y Ding","year":"2021","unstructured":"Ding Y, Tu P, Chen Y, Huang Y, Pan X, Chen W. CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia-reperfusion injury in vivo and in vitro. Respir Res. 2021;221:291.","journal-title":"Respir Res"},{"key":"449_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.prostaglandins.2009.06.004","volume":"913\u20134","author":"JJ Iliff","year":"2010","unstructured":"Iliff JJ, Jia J, Nelson J, Goyagi T, Klaus J, Alkayed NJ. Epoxyeicosanoid signaling in CNS function and disease. Prostaglandins Other Lipid Mediat. 2010;913\u20134:68\u201384.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"449_CR18","doi-asserted-by":"crossref","unstructured":"Ostermann AI, Herbers J, Willenberg I, Chen R, Hwang SH, Greite R et al. Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern. Prostaglandins & other lipid mediators. 2015;121Pt A:131\u2013137.","DOI":"10.1016\/j.prostaglandins.2015.06.005"},{"key":"449_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2004.10.001","volume":"441","author":"JW Newman","year":"2005","unstructured":"Newman JW, Morisseau C, Hammock BD. Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog Lipid Res. 2005;441:1\u201351.","journal-title":"Prog Lipid Res"},{"key":"449_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1369\/jhc.2008.950659","volume":"566","author":"P Sura","year":"2008","unstructured":"Sura P, Sura R, Enayetallah AE, Grant DF. Distribution and expression of soluble epoxide hydrolase in human brain. J Histochem Cytochemistry: Official J Histochem Soc. 2008;566:551\u20139.","journal-title":"J Histochem Cytochemistry: Official J Histochem Soc"},{"key":"449_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.biochi.2019.01.020","volume":"159","author":"SD Kodani","year":"2019","unstructured":"Kodani SD, Morisseau C. Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation. Biochimie. 2019;159:59\u201365.","journal-title":"Biochimie"},{"key":"449_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12035-014-8833-3","volume":"521","author":"X Qin","year":"2015","unstructured":"Qin X, Wu Q, Lin L, Sun A, Liu S, Li X, et al. Soluble epoxide hydrolase deficiency or Inhibition attenuates MPTP-Induced parkinsonism. Mol Neurobiol. 2015;521:187\u201395.","journal-title":"Mol Neurobiol"},{"key":"449_CR23","first-page":"E5815","volume":"11525","author":"Q Ren","year":"2018","unstructured":"Ren Q, Ma M, Yang J, Nonaka R, Yamaguchi A, Ishikawa KI, et al. Soluble epoxide hydrolase plays a key role in the pathogenesis of parkinson\u2019s disease. Proc Natl Acad Sci USA. 2018;11525:E5815\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"449_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12974-017-1005-4","volume":"141","author":"CH Wu","year":"2017","unstructured":"Wu CH, Shyue SK, Hung TH, Wen S, Lin CC, Chang CF, et al. Genetic deletion or Pharmacological Inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage. J Neuroinflamm. 2017;141:230.","journal-title":"J Neuroinflamm"},{"key":"449_CR25","doi-asserted-by":"publisher","first-page":"8188","DOI":"10.1523\/JNEUROSCI.1246-20.2020","volume":"4042","author":"W Chen","year":"2020","unstructured":"Chen W, Wang M, Zhu M, Xiong W, Qin X, Zhu X. 14,15-Epoxyeicosatrienoic acid alleviates pathology in a mouse model of alzheimer\u2019s disease. J Neuroscience: Official J Soc Neurosci. 2020;4042:8188\u2013203.","journal-title":"J Neuroscience: Official J Soc Neurosci"},{"key":"449_CR26","doi-asserted-by":"crossref","unstructured":"Ghosh A, Comerota MM, Wan D, Chen F, Propson NE, Hwang SH, et al. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2020;12:eabb1206.","DOI":"10.1126\/scitranslmed.abb1206"},{"key":"449_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12974-019-1635-9","volume":"161","author":"HT Lee","year":"2019","unstructured":"Lee HT, Lee KI, Chen CH, Lee TS. Genetic deletion of soluble epoxide hydrolase delays the progression of alzheimer\u2019s disease. J Neuroinflamm. 2019;161:267.","journal-title":"J Neuroinflamm"},{"key":"449_CR28","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/j.1476-5381.2011.01641.x","volume":"1655","author":"A Ulu","year":"2012","unstructured":"Ulu A, Appt S, Morisseau C, Hwang SH, Jones PD, Rose TE, et al. Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys. Br J Pharmacol. 2012;1655:1401\u201312.","journal-title":"Br J Pharmacol"},{"key":"449_CR29","doi-asserted-by":"publisher","first-page":"110120","DOI":"10.1016\/j.cbi.2022.110120","volume":"366","author":"YH Siddique","year":"2022","unstructured":"Siddique YH, Rahul, Ara G, Afzal M, Varshney H, Gaur K, et al. Beneficial effects of apigenin on the Transgenic Drosophila model of alzheimer\u2019s disease. Chemico-Biol Interact. 2022;366:110120.","journal-title":"Chemico-Biol Interact"},{"key":"449_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neuro.2018.11.010","volume":"70","author":"N Lakkappa","year":"2019","unstructured":"Lakkappa N, Krishnamurthy PT, M DP, Hammock BD, Hwang SH. Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: implications for parkinson\u2019s disease. Neurotoxicology. 2019;70:135\u201345.","journal-title":"Neurotoxicology"},{"key":"449_CR31","first-page":"234","volume":"41","author":"L Liu Ying","year":"2021","unstructured":"Liu Ying L, Liu G. Effects of polygala tenuifolia saponins on behavior and life span of Tau Transgenic Drosophila model of alzheimer\u2019s disease. Jilin Traditional Chin Med. 2021;41:234\u20137.","journal-title":"Jilin Traditional Chin Med"},{"key":"449_CR32","doi-asserted-by":"publisher","first-page":"210013","DOI":"10.1098\/rsob.210013","volume":"116","author":"V Balendra","year":"2021","unstructured":"Balendra V, Singh SK. Therapeutic potential of Astaxanthin and superoxide dismutase in alzheimer\u2019s disease. Open Biology. 2021;116:210013.","journal-title":"Open Biology"},{"key":"449_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","volume":"107","author":"A Ionescu-Tucker","year":"2021","unstructured":"Ionescu-Tucker A, Cotman CW. Emerging roles of oxidative stress in brain aging and alzheimer\u2019s disease. Neurobiol Aging. 2021;107:86\u201395.","journal-title":"Neurobiol Aging"},{"key":"449_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/dneu.22777","volume":"815","author":"S De Schepper","year":"2021","unstructured":"De Schepper S, Crowley G, Hong S. Understanding microglial diversity and implications for neuronal function in health and disease. Dev Neurobiol. 2021;815:507\u201323.","journal-title":"Dev Neurobiol"},{"key":"449_CR35","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","volume":"532","author":"Y Tang","year":"2016","unstructured":"Tang Y, Le W. Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol. 2016;532:1181\u201394.","journal-title":"Mol Neurobiol"},{"key":"449_CR36","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.2174\/1871527313666140806124850","volume":"139","author":"ME Gambuzza","year":"2014","unstructured":"Gambuzza ME, Sofo V, Salmeri FM, Soraci L, Marino S, Bramanti P. Toll-like receptors in alzheimer\u2019s disease: a therapeutic perspective. CNS Neurol Disord Drug Target. 2014;139:1542\u201358.","journal-title":"CNS Neurol Disord Drug Target"},{"key":"449_CR37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/14728222.2019.1676416","volume":"2310","author":"GR Leitner","year":"2019","unstructured":"Leitner GR, Wenzel TJ, Marshall N, Gates EJ, Klegeris A. Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders. Expert Opin Ther Targets. 2019;2310:865\u201382.","journal-title":"Expert Opin Ther Targets"},{"key":"449_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2020.09.029","volume":"1085","author":"JW Lewcock","year":"2020","unstructured":"Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM, Haass C. Emerging microglia biology defines novel therapeutic approaches for alzheimer\u2019s disease. Neuron. 2020;1085:801\u201321.","journal-title":"Neuron"},{"key":"449_CR39","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1046\/j.1471-4159.1999.0722053.x","volume":"725","author":"K Hensley","year":"1999","unstructured":"Hensley K, Floyd RA, Zheng NY, Nael R, Robinson KA, Nguyen X, et al. p38 kinase is activated in the alzheimer\u2019s disease brain. J Neurochem. 1999;725:2053\u20138.","journal-title":"J Neurochem"},{"key":"449_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","volume":"53","author":"C Morisseau","year":"2013","unstructured":"Morisseau C, Hammock BD. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol. 2013;53:37\u201358.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"449_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0753-3322(02)00193-2","volume":"565","author":"H Tapiero","year":"2002","unstructured":"Tapiero H, Ba GN, Couvreur P, Tew KD. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2002;565:215\u201322.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"449_CR42","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1002\/jnr.24080","volume":"9512","author":"Q Wu","year":"2017","unstructured":"Wu Q, Cai H, Song J, Chang Q. The effects of sEH inhibitor on depression-like behavior and neurogenesis in male mice. J Neurosci Res. 2017;9512:2483\u201392.","journal-title":"J Neurosci Res"},{"key":"449_CR43","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s13311-020-00854-1","volume":"174","author":"C Gri\u00f1\u00e1n-Ferr\u00e9","year":"2020","unstructured":"Gri\u00f1\u00e1n-Ferr\u00e9 C, Codony S, Pujol E, Yang J, Leiva R, Escolano C, et al. Pharmacological Inhibition of soluble epoxide hydrolase as a new therapy for alzheimer\u2019s disease. Neurother: J Am Soc Experimental Neurother. 2020;174:1825\u201335.","journal-title":"Neurother: J Am Soc Experimental Neurother"},{"key":"449_CR44","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/jcbfm.2013.111","volume":"3310","author":"J Wang","year":"2013","unstructured":"Wang J, Fujiyoshi T, Kosaka Y, Raybuck JD, Lattal KM, Ikeda M, et al. Inhibition of soluble epoxide hydrolase after cardiac arrest\/cardiopulmonary resuscitation induces a neuroprotective phenotype in activated microglia and improves neuronal survival. J Cereb Blood Flow Metab. 2013;3310:1574\u201381.","journal-title":"J Cereb Blood Flow Metab"},{"key":"449_CR45","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ejps.2010.03.018","volume":"403","author":"HJ Tsai","year":"2010","unstructured":"Tsai HJ, Hwang SH, Morisseau C, Yang J, Jones PD, Kasagami T, et al. Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs. Eur J Pharm Sci. 2010;403:222\u201338.","journal-title":"Eur J Pharm Sci"},{"key":"449_CR46","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1476-5381.2008.00009.x","volume":"1562","author":"JY Liu","year":"2009","unstructured":"Liu JY, Tsai HJ, Hwang SH, Jones PD, Morisseau C, Hammock BD. Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation. Br J Pharmacol. 2009;1562:284\u201396.","journal-title":"Br J Pharmacol"},{"key":"449_CR47","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3389\/fphar.2019.00464","volume":"10","author":"D Wan","year":"2019","unstructured":"Wan D, Yang J, McReynolds CB, Barnych B, Wagner KM, Morisseau C, et al. In vitro and in vivo metabolism of a potent inhibitor of soluble epoxide hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea. Front Pharmacol. 2019;10:464.","journal-title":"Front Pharmacol"},{"key":"449_CR48","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jpba.2017.11.043","volume":"149","author":"N Lakkappa","year":"2018","unstructured":"Lakkappa N, Krishnamurthy PT, Yamjala K, Hwang SH, Hammock BD, Babu B. Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS\/MS method development. J Pharm Biomed Anal. 2018;149:457\u201364.","journal-title":"J Pharm Biomed Anal"},{"key":"449_CR49","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1101\/gr.169101","volume":"116","author":"LT Reiter","year":"2001","unstructured":"Reiter LT, Potocki L, Chien S, Gribskov M, Bier E. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res. 2001;116:1114\u201325.","journal-title":"Genome Res"},{"key":"449_CR50","doi-asserted-by":"crossref","unstructured":"Cheng X, Song C, Du Y, Gaur U, Yang M. Pharmacological Treatment of Alzheimer\u2019s Disease: Insights from Drosophila melanogaster. Int J Mol Sci. 2020;21:4621.","DOI":"10.3390\/ijms21134621"},{"key":"449_CR51","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1021\/jf60193a058","volume":"223","author":"SS Gill","year":"1974","unstructured":"Gill SS, Hammock BD, Casida JE. Mammalian metabolism and environmental degradation of the juvenoid 1-(4\u2019-ethylphenoxy)-3,7-dimethyl-6,7-epoxy-trans-2-octene and related compounds. J Agric Food Chem. 1974;223:386\u201395.","journal-title":"J Agric Food Chem"},{"key":"449_CR52","doi-asserted-by":"publisher","first-page":"F496","DOI":"10.1152\/ajprenal.00350.2004","volume":"2893","author":"JD Imig","year":"2005","unstructured":"Imig JD. Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. Am J Physiol Ren Physiol. 2005;2893:F496\u2013503.","journal-title":"Am J Physiol Ren Physiol"},{"key":"449_CR53","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nrd2875","volume":"810","author":"JD Imig","year":"2009","unstructured":"Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discovery. 2009;810:794\u2013805.","journal-title":"Nat Rev Drug Discovery"},{"key":"449_CR54","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1038\/sj.jcbfm.9600494","volume":"2712","author":"W Zhang","year":"2007","unstructured":"Zhang W, Koerner IP, Noppens R, Grafe M, Tsai HJ, Morisseau C, et al. Soluble epoxide hydrolase: a novel therapeutic target in stroke. J Cereb Blood Flow Metab. 2007;2712:1931\u201340.","journal-title":"J Cereb Blood Flow Metab"},{"key":"449_CR55","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jinsphys.2004.12.008","volume":"515","author":"DD Anspaugh","year":"2005","unstructured":"Anspaugh DD, Roe RM. Regulation of JH epoxide hydrolase versus JH esterase activity in the cabbage looper, Trichoplusia ni, by juvenile hormone and xenobiotics. J Insect Physiol. 2005;515:523\u201335.","journal-title":"J Insect Physiol"},{"key":"449_CR56","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1271\/bbb.100104","volume":"747","author":"A Seino","year":"2010","unstructured":"Seino A, Ogura T, Tsubota T, Shimomura M, Nakakura T, Tan A, et al. Characterization of juvenile hormone epoxide hydrolase and related genes in the larval development of the silkworm Bombyx mori. Biosci Biotechnol Biochem. 2010;747:1421\u20139.","journal-title":"Biosci Biotechnol Biochem"},{"key":"449_CR57","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/(SICI)1520-6327(1996)32:3\/4<407::AID-ARCH13>3.0.CO;2-G","volume":"323\u20134","author":"GD Prestwich","year":"1996","unstructured":"Prestwich GD, Wojtasek H, Lentz AJ, Rabinovich JM. Biochemistry of proteins that bind and metabolize juvenile hormones. Arch Insect Biochem Physiol. 1996;323\u20134:407\u201319.","journal-title":"Arch Insect Biochem Physiol"},{"key":"449_CR58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ibmb.2014.08.004","volume":"54","author":"J Xu","year":"2014","unstructured":"Xu J, Morisseau C, Hammock BD. Expression and characterization of an epoxide hydrolase from Anopheles gambiae with high activity on epoxy fatty acids. Insect Biochem Mol Biol. 2014;54:42\u201352.","journal-title":"Insect Biochem Mol Biol"},{"key":"449_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ibmb.2015.02.004","volume":"59","author":"J Xu","year":"2015","unstructured":"Xu J, Morisseau C, Yang J, Mamatha DM, Hammock BD. Epoxide hydrolase activities and epoxy fatty acids in the mosquito Culex quinquefasciatus. Insect Biochem Mol Biol. 2015;59:41\u20139.","journal-title":"Insect Biochem Mol Biol"},{"key":"449_CR60","doi-asserted-by":"publisher","first-page":"112516","DOI":"10.1016\/j.fct.2021.112516","volume":"156","author":"CP Sun","year":"2021","unstructured":"Sun CP, Zhang XY, Zhou JJ, Huo XK, Yu ZL, Morisseau C, et al. Inhibition of sEH via stabilizing the level of EETs alleviated alzheimer\u2019s disease through GSK3\u03b2 signaling pathway. Food Chem Toxicology: Int J Published Br Industrial Biol Res Association. 2021;156:112516.","journal-title":"Food Chem Toxicology: Int J Published Br Industrial Biol Res Association"},{"key":"449_CR61","doi-asserted-by":"publisher","first-page":"118664","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"18675","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D. Glycogen synthase kinase-3 signaling in alzheimer\u2019s disease. Biochim Et Biophys Acta Mol Cell Res. 2020;18675:118664.","journal-title":"Biochim Et Biophys Acta Mol Cell Res"},{"key":"449_CR62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuint.2015.10.011","volume":"95","author":"M Venigalla","year":"2016","unstructured":"Venigalla M, Sonego S, Gyengesi E, Sharman MJ, M\u00fcnch G. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in alzheimer\u2019s disease. Neurochem Int. 2016;95:63\u201374.","journal-title":"Neurochem Int"},{"key":"449_CR63","doi-asserted-by":"publisher","first-page":"12050","DOI":"10.1038\/s41598-018-30487-6","volume":"81","author":"A Ng","year":"2018","unstructured":"Ng A, Tam WW, Zhang MW, Ho CS, Husain SF, McIntyre RS, et al. IL-1\u03b2, IL-6, TNF- \u03b1 and CRP in elderly patients with depression or alzheimer\u2019s disease: systematic review and Meta-Analysis. Sci Rep. 2018;81:12050.","journal-title":"Sci Rep"},{"key":"449_CR64","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","volume":"5","author":"C Vaure","year":"2014","unstructured":"Vaure C, Liu Y. A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol. 2014;5:316.","journal-title":"Front Immunol"},{"key":"449_CR65","doi-asserted-by":"crossref","unstructured":"Sun E, Motolani A, Campos L, Lu T. The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer\u2019s Disease. Int J Mol Sci. 2022;23:8972.","DOI":"10.3390\/ijms23168972"},{"key":"449_CR66","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.phrs.2017.11.030","volume":"129","author":"EJ Seo","year":"2018","unstructured":"Seo EJ, Fischer N, Efferth T. Phytochemicals as inhibitors of NF-\u03baB for treatment of alzheimer\u2019s disease. Pharmacol Res. 2018;129:262\u201373.","journal-title":"Pharmacol Res"},{"key":"449_CR67","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jocn.2013.08.017","volume":"215","author":"S Wang","year":"2014","unstructured":"Wang S, Zhang C, Sheng X, Zhang X, Wang B, Zhang G. Peripheral expression of MAPK pathways in alzheimer\u2019s and parkinson\u2019s diseases. J Clin Neuroscience: Official J Neurosurgical Soc Australasia. 2014;215:810\u20134.","journal-title":"J Clin Neuroscience: Official J Neurosurgical Soc Australasia"},{"key":"449_CR68","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1007\/s12035-022-02909-0","volume":"599","author":"H Lin","year":"2022","unstructured":"Lin H, Dixon SG, Hu W, Hamlett ED, Jin J, Ergul A, et al. p38 MAPK is a major regulator of amyloid Beta-Induced IL-6 expression in human microglia. Mol Neurobiol. 2022;599:5284\u201398.","journal-title":"Mol Neurobiol"},{"key":"449_CR69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1515\/revneuro-2018-0008","volume":"301","author":"G Kheiri","year":"2018","unstructured":"Kheiri G, Dolatshahi M, Rahmani F, Rezaei N. Role of p38\/MAPKs in alzheimer\u2019s disease: implications for amyloid beta toxicity targeted therapy. Rev Neurosci. 2018;301:9\u201330.","journal-title":"Rev Neurosci"}],"container-title":["Journal of Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-025-00449-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12950-025-00449-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-025-00449-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T21:03:02Z","timestamp":1750712582000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal-inflammation.biomedcentral.com\/articles\/10.1186\/s12950-025-00449-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1186\/s12950-025-00449-7","relation":{},"ISSN":["1476-9255"],"issn-type":[{"value":"1476-9255","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All listed authors consent to the submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}